A New Way To Make Vaccines

November 11, 1997

A team of chemists from Birmingham University has succeeded in making a completely synthetic vaccine. The vaccine, which contains no biologically derived components, could represent the first stage in the development of a new generation 'minimalist' vaccines with potentially fewer side-effects than their conventional counterparts.

The work, carried out by a team led by Dr Geert-Jan Boons, is part- funded by the Engineering and Physical Sciences Research Council.

While synthetic vaccines are unlikely to become available for several years, the research has demonstrated that it should be feasible to build, step by step, a system that mimics conventional vaccines.

When the body is invaded by a pathogen, antibodies recognise specific molecules on the surface of the pathogen - termed 'epitopes' - and trigger the immune response.

Vaccination involves triggering the immune response in the absence of a genuine infection, thereby 'arming' the body for the real thing.

The first vaccines used whole cells of pathogens that had been killed or 'crippled'.

Subsequent refinement of vaccines involved attempting to isolate only that part of the organism's surface that contained the relevant epitope. However, such vaccines can still incorporate extraneous material that is unnecessary for the immune response and which can cause complications.

The Birmingham team approached the problem from a different angle. Epitopes are often oligosaccharides - molecules made up of a small number of sugar sub-units. By studying the human pathogen Neisseria meningiditis, the team focused on the crucial portion of the epitope.

Synthesising the epitope in the laboratory was difficult. Not only did the specific sugar sub-units need to be arranged correctly in relation to one another, but the molecule's three-dimensional conformation in space needed to be precise. Using computer models coupled with complex synthetic chemistry techniques, the team succeeded re-creating the epitope. This was then attached to a synthetic peptide and a lipid - two other essential components of a vaccine.

"Realistically I do not think we will see this kind of vaccine in this century," says Dr Boons. "But if we can improve our synthetic methodology I think this will be the new generation of vaccines."

-ends-


Contacts:
Dr Boons.
Tel: 0121 414 4460
fax: 0121 414 4403
e-mail: gjboons@chemistry.bham.ac.uk


Frank Albrighton, external relations director.
Tel: 0121 414 6679
fax: 0121 414 3984
e-mail: f.c.albrighton@bham.ac.uk

Engineering and Physical Sciences Research Council

Related Immune Response Articles from Brightsurf:

Boosting chickens' own immune response could curb disease
Broiler chicken producers the world over are all too familiar with coccidiosis, a parasite-borne intestinal disease that stalls growth and winnows flocks.

Cells sacrifice themselves to boost immune response to viruses
Whether flu or coronavirus, it can take several days for the body to ramp up an effective response to a viral infection.

Children's immune response more effective against COVID-19
Children and adults exhibit distinct immune system responses to infection by the virus that causes COVID-19, a finding that helps explain why COVID-19 outcomes tend to be much worse in adults, researchers from Yale and Albert Einstein College of Medicine report Sept.

Which immune response could cause a vaccine against COVID-19?
Immune reactions caused by vaccination can help protect the organism, or sometimes may aggravate the condition.

Obesity may alter immune system response to COVID-19
Obesity may cause a hyperactive immune system response to COVID-19 infection that makes it difficult to fight off the virus, according to a new manuscript published in the Endocrine Society's journal, Endocrinology.

Immune response to Sars-Cov-2 following organ transplantation
Even patients with suppressed immune systems can achieve a strong immune response to Sars-Cov-2.

'Relaxed' T cells critical to immune response
Rice University researchers model the role of relaxation time as T cells bind to invaders or imposters, and how their ability to differentiate between the two triggers the body's immune system.

A novel mechanism that triggers a cellular immune response
Researchers at Baylor College of Medicine present comprehensive evidence that supports a novel trigger for a cell-mediated response and propose a mechanism for its action.

Platelets exacerbate immune response
Platelets not only play a key role in blood clotting, but can also significantly intensify inflammatory processes.

How to boost immune response to vaccines in older people
Identifying interventions that improve vaccine efficacy in older persons is vital to deliver healthy ageing for an ageing population.

Read More: Immune Response News and Immune Response Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.